News | May 13, 2024
Briefs: Lupin and Aurobindo Pharma
Lupin updates on shipment of Mirabegron ER Tablets
Lupin updates on shipment of Mirabegron ER Tablets
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
The cash consideration for the above acquisition will be Euro 26 million.
Arformoterol Tartrate Inhalation Solution is for treatment of bronchoconstriction
The company recently incorporated a new entity in the name of Lupin Digital Health Limited
It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021
Intrarosa will not only expand and strengthen our product portfolio into Women's Health in Canada but will cater to satisfy the unmet medical needs.
Reflecting on the learning during the pandemic, industry is aiming to push innovation in R&D and implement automation and digital technologies across various operational levels.
While top industry leaders are optimistic about the growth, they expect the special incentives and regulatory streamlining from the government’s side
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)